UCB SA has 15,127 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 6.2%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With more than 8700 employees in approximately 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2022 Key Financials: €5.5 billion global revenue Specialties: Neurology, Immunology
As of September 2025
UCB
workforce metrics
Headcount
15.1k
Avg. Salary
$109.3k
Tenure
5.0yr
Growth Rate
6.2%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of UCB annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of UCB annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?